Removing drops from procedure increases adherence and comfort for most patients.
Ophthalmology Times: October 2024
Corneal confocal microscopy, semaglutide therapy offer treatment options
OCT-based AI analysis brings changes in GA and therapeutic responses into sharp focus.
A time line marked by innovation, collaboration, and improving patient outcomes.
A study clarifies the relationship between postnatal weight gain and ROP development.
The retina is a key proving ground for long-held theories of genetics.
Custom-designed, lens-based surgery is a less interventional surgical option.
While anxiety and depression may cause vision loss, physicians can offer hope
A Norwegian study demonstrates that transplant rates continue to drop over time
Researchers find a strong link between Alzheimer's disease and retinal thinning
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Glaukos receives FDA approval for Epioxa topical therapy for keratoconus
2
Dompé's NAION program selected for FDA Commissioner’s National Priority Voucher Program
3
Q&A: Insights from Rajesh K. Rajpal, MD, on an incision-free keratoconus therapy
4
Aurion Biotech releases positive 12-month results from phase 1/2 CLARA trial
5
.png "Optometry Times"){kind=logo}
